Drew, Simon C.

Mixed Ligand Cu 2+ Complexes of a Model Therapeutic with Alzheimer’s Amyloid-β Peptide and Monoamine Neurotransmitters

Kenche, V. B., Zawisza, I., Masters, C. L., Bal, W., Barnham, K. J., & Drew, S. C. (2013) · Inorganic Chemistry

Alzheimer's disease research and treatmentsMetal complexes synthesis and properties

Cited by 59

Copper Exchange and Redox Activity of a Prototypical 8-Hydroxyquinoline: Implications for Therapeutic Chelation

Mital, M., Zawisza, I. A., Wiloch, M. Z., Wawrzyniak, U. E., Kenche, V., Wróblewski, W., Bal, W., & Drew, S. C. (2016) · Inorganic Chemistry

Alzheimer's disease research and treatmentsMetal complexes synthesis and properties

Cited by 32

The N Terminus of α‐Synuclein Forms Cu II ‐Bridged Oligomers

Drew, S. C. (2015) · Chemistry – A European Journal

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 26

Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate

Bossak-Ahmad, K., Wiśniewska, M. D., Bal, W., Drew, S. C., & Frączyk, T. (2020) · International Journal of Molecular Sciences

Metal complexes synthesis and propertiesTrace Elements in Health

Cited by 25

Interactions of α-Factor-1, a Yeast Pheromone, and Its Analogue with Copper(II) Ions and Low-Molecular-Weight Ligands Yield Very Stable Complexes

Bossak, K., Mital, M., Poznański, J., Bonna, A., Drew, S., & Bal, W. (2016) · Inorganic Chemistry

Metal complexes synthesis and propertiesTrace Elements in Health

Cited by 23

Probing the quaternary structure of metal-bridged peptide oligomers

Drew, S. C. (2016) · Journal of Inorganic Biochemistry

Electron Spin Resonance StudiesParkinson's Disease Mechanisms and Treatments

Cited by 10